Accuray rolls out Helix to boost cancer treatment in India

Accuray rolls out Helix to boost cancer treatment in India



With rising circumstances of most cancers in India, Accuray which is into radiation remedy, stated it was stepping as much as assist most cancers therapy with the introduction of Accuray Helix, a configuration of Radixact Therapy Supply System in India.

“Accuray Helix brings flexibility and flexibility and is meant to drive enhancements in personalisation and affected person care, whereas concurrently facilitating therapy of extra sufferers every day, boosting productiveness for clinics and enabling them to effectively handle the rising demand for most cancers care,” the corporate stated in a press release.

It permits healthcare suppliers to deal with a broad vary of most cancers varieties even in clinics in smaller cities. “Our imaginative and prescient is to increase the healing energy of radiation remedy to enhance as many lives as attainable, regardless of the place they’re positioned,” Xavier De Misouard, President & Common Supervisor – EIMEA, Accuray stated in a press release. 

“Accuray Helix is designed to bridge gaps in care entry throughout nations like India. By offering superior, quick, and exact remedies, we’re enabling medical groups to succeed in extra sufferers and assist enhance outcomes nationwide,” he added.  

Vidhi Prasad, Managing Director, India & Subcontinent, Accuray stated, “We’re actively working with healthcare suppliers all throughout India to ship precision expertise for most cancers care. We attempt to empower healthcare professionals to handle elevated affected person hundreds with out compromising the standard of care, serving to to make sure that no affected person is left behind.”

Projections point out a 12.8% improve in most cancers circumstances by 2025 in India. At present, India sees about 1.4 million new most cancers circumstances yearly, and that is anticipated to extend. It’s estimated that 50-60% of sufferers with most cancers will want radiotherapy.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *